Studies in rat models that mimicked diabetes mellitus type 1 (streptozotocin-induced) and diabetes mellitus type 2 (high-fat diet-fed rats) observed that the daily administration of apelin-13 ameliorated insulin sensitivity and decreased plasma glucose levels [68]. This evidence concerns the gene INS and type 2 diabetes mellitus.